Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19
Objective. To detect biomarkers that can be used to predict COVID-19 severity to identify patients with high probability of disease progression and poor prognosis. Methods. Of the 102 patients with confirmed COVID-19 who were admitted to King Fahd General Hospital, Jeddah City, Saudi Arabia, from Ju...
Saved in:
Main Authors: | Amal A. Abbas, Asma Alghamdi, Sonia Mezghani, Mourad Ben Ayed, Ahmed M. Alamori, Ghazi A. Alghamdi, Wail Bajhmom, Hanan Wajeeh, Salma S. Almutairi, Wafaa M. Radwan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/6336556 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan
by: Naoya Nakashima, et al.
Published: (2022-06-01) -
Diagnostic Predictive Value of Tryptase, Serum Amyloid A and Lipoprotein-Associated Phospholipase A2 Biomarker Groups for Large Atherosclerotic Cerebral Infarction
by: Wenhui Jia, et al.
Published: (2022-01-01) -
Haptoglobin and serum amyloid a in subacute ruminal acidosis in goats
by: F.H.D. González, et al.
Published: (2010-01-01) -
Dual Effect of Serum Amyloid A on the Invasiveness of Glioma Cells
by: Franciele Hinterholz Knebel, et al.
Published: (2013-01-01) -
Galectin-3: A Novel Marker for the Prediction of Stroke Incidence and Clinical Prognosis
by: Ahmed Sayed, et al.
Published: (2022-01-01)